Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 13, 2012 - Issue 1
Submit an article Journal homepage
241
Views
9
CrossRef citations to date
0
Altmetric
Original Investigations

Aripiprazole augmentation in 13 patients with refractory obsessive-compulsive disorder: A case series

Haruka HigumaDepartment of Neuropsychiatry, Oita University Faculty of Medicine, Oita, Japan
,
Masayuki KanehisaDepartment of Neuropsychiatry, Oita University Faculty of Medicine, Oita, Japan
,
Yoshihiro MaruyamaDepartment of Neuropsychiatry, Oita University Faculty of Medicine, Oita, Japan
,
Yoshinobu IshitobiDepartment of Neuropsychiatry, Oita University Faculty of Medicine, Oita, Japan
,
Yoshihiro TanakaDepartment of Neuropsychiatry, Oita University Faculty of Medicine, Oita, Japan
,
Jusen TsuruDepartment of Neuropsychiatry, Oita University Faculty of Medicine, Oita, Japan
,
Hiroaki HanadaDepartment of Neuropsychiatry, Oita University Faculty of Medicine, Oita, Japan
,
Kensuke KodamaDepartment of Neuropsychiatry, Oita University Faculty of Medicine, Oita, Japan
,
Koichi IsogawaDepartment of Neuropsychiatry, Oita University Faculty of Medicine, Oita, Japan
&
Jotaro AkiyoshiDepartment of Neuropsychiatry, Oita University Faculty of Medicine, Oita, JapanCorrespondence[email protected]
 show all
Pages 14-21 | Received 02 Jul 2010, Accepted 14 Dec 2010, Published online: 19 Jan 2012

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Vlasios Brakoulias & Emily Stockings. (2019) A systematic review of the use of risperidone, paliperidone and aripiprazole as augmenting agents for obsessive-compulsive disorder. Expert Opinion on Pharmacotherapy 20:1, pages 47-53.
Read now
Shyam Sundar Arumugham & Janardhan YC Reddy. (2013) Augmentation strategies in obsessive–compulsive disorder. Expert Review of Neurotherapeutics 13:2, pages 187-203.
Read now

Articles from other publishers (7)

Ali TalaeiFarhad Farid HosseiniZahra AghiliShahin AkhondzadehElham AsadpourNeema John MehramizFatemeh Forouzanfar. (2020) A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Canadian Journal of Physiology and Pharmacology 98:4, pages 236-242.
Crossref
Murat Eren ÖZEN, Aysun KALENDEROĞLU, Mustafa ÇELİK, Mehmet Hamdi ÖRÜM & Çiçek HOCAOĞLU. (2019) Obsesif Kompulsif Bozukluk Güçlendirme Tedavisinde Aripiprazol, Klomipramin ve Buspironun Etkinliği: Retrospektif Bir AraştırmaEfficacy of Aripiprazole, Clomipramine, and Buspirone in Obsessive Compulsive Disorder Augmentation Therapy: A Retrospective Study. Adıyaman Üniversitesi Sağlık Bilimleri Dergisi 5:1, pages 1293-1302.
Crossref
Dongmi Kim, Nicole L. Ryba, Julie Kalabalik & Ligia Westrich. (2018) Critical Review of the Use of Second-Generation Antipsychotics in Obsessive–Compulsive and Related Disorders. Drugs in R&D 18:3, pages 167-189.
Crossref
Ulku Akyol Ardic, Eyup Sabri Ercan, Ayse Kutlu, Deniz Yuce, Melis Ipci & Sevim Berrin Inci. (2016) Successful Treatment Response with Aripiprazole Augmentation of SSRIs in Refractory Obsessive–Compulsive Disorder in Childhood. Child Psychiatry & Human Development 48:5, pages 699-704.
Crossref
Fatemeh Assarian, Fatemeh Sadat Ghoreishi, Mahbubeh Borna & Mohammadreza Razzaghof. (2016) The Efficacy of Aripiprazole versus Risperidone as Augmentation Therapy in the Treatment of the Resistant Obsessive-Compulsive Disorder: A Double-Blind Clinical Trial. Iranian Red Crescent Medical Journal 20:5.
Crossref
Hans-Peter Volz. 2016. Polypharmazie in der Behandlung psychischer Erkrankungen. Polypharmazie in der Behandlung psychischer Erkrankungen 209 233 .
Xenia Borue, Mehak Sharma & Robert Hudak. (2015) Biological treatments for obsessive-compulsive and related disorders. Journal of Obsessive-Compulsive and Related Disorders 6, pages 7-26.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.